Holen Sie sich die Stockscreener-App
9.18
3.61%
0.32
Schlusskurs vom Vortag:
$8.86
Offen:
$8.9
24-Stunden-Volumen:
45,537
Relative Volume:
0.67
Marktkapitalisierung:
$255.33M
Einnahmen:
$21.25M
Nettoeinkommen (Verlust:
$-16.05M
KGV:
-15.05
EPS:
-0.61
Netto-Cashflow:
$-17.14M
1W Leistung:
+3.49%
1M Leistung:
+10.34%
6M Leistung:
+36.40%
1J Leistung:
+65.11%
1-Tages-Spanne:
$8.84
$9.18
1-Wochen-Bereich:
$8.73
$9.18
52-Wochen-Spanne:
$3.96
$9.42
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
Firmenname
Fennec Pharmaceuticals Inc
Sektor
Branche
Telefon
(919) 636-4530
Adresse
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Vergleichen Sie FENC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
9.18 | 247.98M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-11-22 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2022-09-07 | Eingeleitet | CapitalOne | Overweight |
| 2022-08-08 | Fortgesetzt | Craig Hallum | Buy |
| 2020-06-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-10-11 | Eingeleitet | Goldman | Buy |
Fennec Pharmaceuticals Inc Aktie (FENC) Neueste Nachrichten
Ranking Fennec Pharmaceuticals Inc. among high performing stocks via toolsJuly 2025 Levels & Real-Time Buy Signal Alerts - Newser
How Fennec Pharmaceuticals Inc. stock performs during market volatility2025 Key Lessons & Free Verified High Yield Trade Plans - Newser
FenneC Pharmaceuticals Director Raykov Rosty Sells 10,000 Shares for $8.92 Each. - AInvest
Is Fennec Pharmaceuticals Inc.’s growth already priced inTrade Ideas & Free Community Supported Trade Ideas - khodrobank.com
Is Fennec Pharmaceuticals Inc. a candidate for recovery play2025 Valuation Update & Accurate Entry and Exit Point Alerts - Newser
Is Fennec Pharmaceuticals Inc. stock bottoming outMarket Growth Report & Risk Managed Trade Strategies - Newser
Fennec Pharmaceuticals Inc. stock trendline breakdownTrade Entry Summary & Reliable Trade Execution Plans - Newser
Combining machine learning predictions for Fennec Pharmaceuticals Inc.Market Performance Report & Verified Stock Trade Ideas - Newser
Is this a good reentry point in Fennec Pharmaceuticals Inc.Trend Reversal & Entry and Exit Point Strategies - Newser
Using data models to predict Fennec Pharmaceuticals Inc. stock movementTrade Exit Summary & Daily Growth Stock Tips - Newser
Custom strategy builders for tracking Fennec Pharmaceuticals Inc.2025 Market Sentiment & Growth Focused Investment Plans - Newser
Pattern recognition hints at Fennec Pharmaceuticals Inc. upsideJuly 2025 Trade Ideas & Real-Time Market Sentiment Alerts - Newser
What’s the fair value of Fennec Pharmaceuticals Inc. stockEntry Point & Smart Money Movement Alerts - khodrobank.com
Tools to monitor Fennec Pharmaceuticals Inc. recovery probability2025 Year in Review & Free High Accuracy Swing Entry Alerts - Newser
Using Python tools to backtest Fennec Pharmaceuticals Inc. strategiesWeekly Market Outlook & Accurate Technical Buy Alerts - Newser
Exit strategy if you’re trapped in Fennec Pharmaceuticals Inc.2025 Top Decliners & Technical Pattern Recognition Alerts - Newser
Has Fennec Pharmaceuticals Inc. found a price floorQuarterly Market Review & Expert Approved Momentum Trade Ideas - Newser
Fennec Pharmaceuticals Inc. stock daily chart insightsJuly 2025 Action & High Accuracy Swing Entry Alerts - Newser
Is Fennec Pharmaceuticals Inc. forming a bottoming baseEarnings Risk Summary & Risk Controlled Swing Trade Alerts - Newser
Published on: 2025-09-03 04:52:27 - Newser
Analyzing Fennec Pharmaceuticals Inc. with risk reward ratio chartsQuarterly Investment Review & Real-Time Market Sentiment Alerts - Newser
Using R and stats models for Fennec Pharmaceuticals Inc. forecastingBear Alert & Low Risk High Reward Trade Ideas - Newser
Forecasting Fennec Pharmaceuticals Inc. price range with options dataWeekly Gains Report & Community Verified Trade Alerts - Newser
How much upside does Fennec Pharmaceuticals Inc. have2025 Growth vs Value & Step-by-Step Swing Trade Plans - khodrobank.com
Is Fennec Pharmaceuticals Inc. stock trending bullishWeekly Stock Report & Weekly High Momentum Picks - khodrobank.com
Analyzing net buyer seller activity in Fennec Pharmaceuticals Inc.2025 Risk Factors & AI Forecasted Entry and Exit Points - Newser
Tools to assess Fennec Pharmaceuticals Inc.’s risk profileJuly 2025 Spike Watch & Reliable Price Action Trade Plans - Newser
What is Fennec Pharmaceuticals Inc.’s valuation compared to sector2025 Investor Takeaways & Precise Trade Entry Recommendations - khodrobank.com
Is Fennec Pharmaceuticals Inc. subject to activist investor interestMarket Risk Analysis & Real-Time Price Movement Reports - khodrobank.com
Short Covering: What is Fennec Pharmaceuticals Inc.’s valuation compared to sectorLayoff News & Technical Buy Zone Confirmation - khodrobank.com
What momentum shifts mean for Fennec Pharmaceuticals Inc.July 2025 Technicals & Daily Entry Point Alerts - Newser
Is Fennec Pharmaceuticals Inc. stock ready for a breakoutLong Setup & Fast Gain Swing Trade Alerts - Newser
Fennec Pharmaceuticals Inc. Consolidation Zone May Signal Accumulation getLinesFromResByArray error: size == 0 - 강소기업뉴스
Fennec Pharmaceuticals Inc. stock outlook for YEARVolume Spike & AI Driven Stock Reports - Newser
What Fibonacci levels say about Fennec Pharmaceuticals Inc. reboundWeekly Investment Recap & Weekly Return Optimization Plans - Newser
Can a trend reversal in Fennec Pharmaceuticals Inc. lead to recoveryJuly 2025 PostEarnings & Consistent Profit Focused Trading Strategies - Newser
Finanzdaten der Fennec Pharmaceuticals Inc-Aktie (FENC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):